Events

Recall of BD BBL VANCOMYCIN SCREEN AGAR (VSA)

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by BECTON DICKINSON CANADA INC..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    33124
  • Event Risk Class
    II
  • Event Initiated Date
    2013-06-07
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Bd has confirmed reports that the above referenced lots of product may exhibit reduced levels of vancomycin. this may result in two scenarios: - breakthrough growth of vancomycin susceptible enterococcus species control organisms and/or patient isolates on bd bbl vancomycin screen agaror - reduced inhibition of normal flora on all other media types listed above.

Device

BD BBL VANCOMYCIN SCREEN AGAR (VSA)
  • Model / Serial
    Model Catalog: 222204 (Lot serial: 3081136); Model Catalog: 222204 (Lot serial: 3073114); Model Catalog: 299614 (Lot serial: 3078430); Model Catalog: 297880 (Lot serial: 3078348)
  • Product Description
    BD BBL Vancomycin Screen Agar (VSA)
  • Manufacturer
    BECTON DICKINSON CANADA INC.

Manufacturer

BECTON DICKINSON CANADA INC.